Trial Profile
Safety and tolerability KAF-156 in healthy adult volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 27 Nov 2015
Price :
$35
*
At a glance
- Drugs Ganaplacide (Primary)
- Indications Falciparum malaria; Vivax malaria
- Focus Adverse reactions; First in man; Pharmacokinetics
- Sponsors Novartis
- 27 Nov 2015 New trial record